SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    B.J. Steinhoff, Antikonvulsive Pharmakotherapie Jugendlicher und Erwachsener, Zeitschrift für Epileptologie, 2013, 26, 3, 142

    CrossRef

  2. 2
    Meir Bialer, Tawfeeq Shekh-Ahmad, Tricia L. Braun, Mark B. Halvorsen, Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation, Epilepsia, 2013, 54, 8
  3. 3
    Pieter Dylst, Arnold Vulto, Steven Simoens, Demand-side policies to encourage the use of generic medicines: an overview, Expert Review of Pharmacoeconomics & Outcomes Research, 2013, 13, 1, 59

    CrossRef

  4. 4
    A. Sommet, B. Georgel, J.-C. Poutrain, S. Oustric, R. Bourrel, J.-L. Montastruc, J. Birebent, Différences de taux de substitution des médicaments génériques en Midi-Pyrénées en fonction des classes pharmaco-thérapeutiques, Revue d'Épidémiologie et de Santé Publique, 2013, 61, 6, 539

    CrossRef

  5. 5
    A. Johnston, Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation, European Journal of Hospital Pharmacy: Science and Practice, 2013, 20, 5, 302

    CrossRef

  6. 6
    Jennifer Meyer, David Fardo, Steven T. Fleming, Claudia Hopenhayn, Yevgeniya Gokun, Melody Ryan, Generic antiepileptic drug prescribing: A cross-sectional study, Epilepsy & Behavior, 2013, 26, 1, 1

    CrossRef

  7. 7
    Katrin Hensler, Carmen Uhlmann, Thomas Porschen, Reiner Benecke, Johannes Rösche, Generic substitution of antiepileptic drugs — A survey of patients' perspectives in Germany and other German-speaking countries, Epilepsy & Behavior, 2013, 27, 1, 135

    CrossRef

  8. 8
    Y Yu, S Teerenstra, F Vanmolkot, C Neef, D Burger, M Maliepaard, Interchangeability of Gabapentin Generic Formulations in the Netherlands: A Comparative Bioavailability Study, Clinical Pharmacology & Therapeutics, 2013, 94, 4, 519

    CrossRef

  9. 9
    Marion Bankstahl, Jens P Bankstahl, Wolfgang Löscher, Is switching from brand name to generic formulations of phenobarbital associated with loss of antiepileptic efficacy?: a pharmacokinetic study with two oral formulations (Luminal® vet, Phenoleptil®) in dogs, BMC Veterinary Research, 2013, 9, 1, 202

    CrossRef

  10. 10
    Antonio De Vuono, Francesca Scicchitano, Caterina Palleria, Emilio Russo, Giovambattista De Sarro, Luca Gallelli, Lack of efficacy during the switch from brand to generic allopurinol, Journal of Forensic and Legal Medicine, 2013, 20, 5, 540

    CrossRef

  11. 11
    Vangelis Karalis, Meir Bialer, Panos Macheras, Quantitative assessment of the switchability of generic products, European Journal of Pharmaceutical Sciences, 2013, 50, 3-4, 476

    CrossRef

  12. 12
    Maren Carbon, Christoph U. Correll, Rational Use of Generic Psychotropic Drugs, CNS Drugs, 2013, 27, 5, 353

    CrossRef

  13. 13
    Joseph I. Sirven, Katherine Noe, Matthew Hoerth, Joseph Drazkowski, Antiepileptic Drugs 2012: Recent Advances and Trends, Mayo Clinic Proceedings, 2012, 87, 9, 879

    CrossRef

  14. 14
    Carlos Abud-Mendoza, Ética médica, investigación y la industria farmacéutica, Reumatología Clínica, 2012, 8, 5, 233

    CrossRef

  15. 15
    Barry E. Gidal, Generic Antiepileptic Drugs: How Good Is Close Enough?, Epilepsy Currents, 2012, 12, 1, 32

    CrossRef

  16. 16
    Daniel M. Hartung, Luke Middleton, Leanne Svoboda, Jessina C. McGregor, Generic Substitution of Lamotrigine Among Medicaid Patients with Diverse Indications, CNS Drugs, 2012, 26, 8, 707

    CrossRef

  17. 17
    Carlos Abud-Mendoza, Medical Ethics, Research and the Pharmaceutical Industry, Reumatología Clínica (English Edition), 2012, 8, 5, 233

    CrossRef

  18. 18
    Paul Boon, Sebastiaan Engelborghs, Henri Hauman, An Jansen, Lieven Lagae, Benjamin Legros, Michel Ossemann, Bernard Sadzot, Katrien Smets, Etienne Urbain, Kenou Rijckevorsel, Recommendations for the treatment of epilepsy in adult patients in general practice in Belgium: an update, Acta Neurologica Belgica, 2012, 112, 2, 119

    CrossRef

  19. 19
    Luther Gwaza, John Gordon, Jan Welink, Henrike Potthast, Henrik Hansson, Matthias Stahl, Alfredo García-Arieta, Statistical approaches to indirectly compare bioequivalence between generics: a comparison of methodologies employing artemether/lumefantrine 20/120 mg tablets as prequalified by WHO, European Journal of Clinical Pharmacology, 2012, 68, 12, 1611

    CrossRef

  20. 20
    Forum, Pharmaceutical Medicine, 2011, 25, 5, 331

    CrossRef

  21. 21
    Flint Russett, Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy, Hospital Pharmacy, 2011, 46, 10, 815

    CrossRef

  22. 22
    John W. Miller, Choosing, Initiating, Adjusting, and Changing Antiepileptic Medications,